CCRN logo

Cross Country Healthcare, Inc. Stock Price

NasdaqGS:CCRN Community·US$410.5m Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 3 Fair Values set on narratives written by author

CCRN Share Price Performance

US$13.24
0.69 (5.50%)
US$12.60
Fair Value
US$13.24
0.69 (5.50%)
5.1% overvalued intrinsic discount
US$12.60
Fair Value
Price US$13.24
AnalystConsensusTarget US$12.60
AnalystHighTarget US$13.25
AnalystLowTarget US$10.00

CCRN Community Narratives

·
Fair Value US$12.6 5.1% overvalued intrinsic discount

Full Client Integration With Intellify Will Improve Client Retention

0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
·
Fair Value US$13.25 0.08% undervalued intrinsic discount

Flexible Labor And Tech-Enabled Staffing Will Reshape Earnings Power Over The Next Decade

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
·
Fair Value US$10 32.4% overvalued intrinsic discount

Technology And Mix Shift Will Likely Constrain Margins And Limit Long-Term Upside

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative

Trending Discussion

No trending discussion available.

Updated Narratives

CCRN logo

CCRN: Pending Buyout And Platform Partnership Will Shape Balanced Future Prospects

Fair Value: US$13.25 0.08% undervalued intrinsic discount
0 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
CCRN logo

CCRN: Downgrade And Sale Agreement Will Likely Pressure Future Returns

Fair Value: US$10 32.4% overvalued intrinsic discount
0 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
CCRN logo

CCRN: Buyout Premium And Margin Recovery Expectations Will Anchor Future Share Performance

Fair Value: US$12.6 5.1% overvalued intrinsic discount
1 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Flawless balance sheet and undervalued.

0 Risks
3 Rewards

Cross Country Healthcare, Inc. Key Details

US$1.0b

Revenue

US$799.4m

Cost of Revenue

US$202.5m

Gross Profit

US$301.1m

Other Expenses

-US$98.6m

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
n/a
-3.18
20.21%
-9.84%
0%
View Full Analysis

About CCRN

Founded
1986
Employees
7890
CEO
Kevin Clark
WebsiteView website
www.crosscountry.com

Cross Country Healthcare, Inc. provides talent management services for healthcare clients in the United States. The company operates in two segments: Nurse and Allied Staffing, and Physician Staffing. The Nurse and Allied Staffing segment provides traditional staffing, recruiting, and value-added total talent solutions, including temporary and permanent placement of travel nurse and allied professionals, per diem, and healthcare leaders within nursing, allied, human resources, and finance; vendor neutral and managed services programs; and education healthcare, caregiver services, and outsourcing services. This segment offers staffing solutions for registered nurses, licensed practical nurses, certified nurse assistants, practitioners, pharmacists, and other allied professionals on per diem and short-term assignments; and clinical and non-clinical professionals on long-term assignments, as well as workforce solutions, including MSP, VMS, RPO, project management, and other outsourcing and consultative services. It also provides retained search services for healthcare professionals, as well as contingent search and recruitment process outsourcing services. The company serves public and private acute care and non-acute care hospitals, government facilities, local and national healthcare plans, managed care providers, public and charter schools, outpatient clinics, ambulatory care facilities, correctional facilities, PACE programs, physician practice groups, and other healthcare providers. The Physician Staffing segment provides physicians in various specialties, certified registered nurse anesthetists, nurse practitioners, and physician assistants as independent contractors on temporary assignments. This segment serves various healthcare facilities, such as acute and non-acute care facilities, medical group practices, government facilities, and managed care organizations. The company was founded in 1986 and is headquartered in Boca Raton, Florida.

Recent CCRN News & Updates

Narrative Update Jul 16

CCRN: Pending Buyout And Platform Partnership Will Shape Balanced Future Prospects

Analysts have reduced their price target for Cross Country Healthcare from $15.00 to $13.25, citing updated assumptions around revenue growth, profit margins, discount rates, and future P/E expectations. What’s in the News for Cross Country Healthcare Knox Lane LP agreed to acquire Cross Country Healthcare for $13.25 per share in an all cash deal valued at about $437 million.
Narrative Update Jul 02

CCRN: Downgrade And Sale Agreement Will Likely Pressure Future Returns

The analyst price target for Cross Country Healthcare has shifted from $8.65 to $10.00 as analysts reassess fair value, the discount rate, revenue growth, profit margin, and future P/E assumptions following recent research commentary and a downgrade at Citizens. What’s in the News for Cross Country Healthcare Knox Lane entered into a definitive agreement to acquire Cross Country Healthcare in an all cash transaction valued at approximately $437 million.
Narrative Update Jun 18

CCRN: Buyout Premium And Margin Recovery Expectations Will Anchor Future Share Performance

Analysts have adjusted their price target for Cross Country Healthcare stock slightly higher to about $12.60, citing updated fair value estimates and a modestly higher assumed future P/E multiple, despite a recent downgrade in Street research. What’s in the News for Cross Country Healthcare Knox Lane LP agreed to acquire Cross Country Healthcare in an all cash transaction valued at about $437 million, with stockholders to receive $13.25 per share, pending approvals and closing conditions.

Recent updates

No updates